Drug profile · INN
sirolimus
OPSIRIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sirolimus (OPSIRIA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN sirolimus
Brand OPSIRIA
Route TOPICAL
Formulation POWDER
ATC code L04AH01
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is sirolimus?
sirolimus (OPSIRIA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for sirolimus?
OPSIRIA is a marketed brand name for sirolimus. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sirolimus?
sirolimus has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.